Search research articles
Contact Us
Filters
Showing results (871-880 of 885) with videos related to
Page
of 89
Sort By:
Ebiomedicine
|
April 16, 2021
Corrigendum to 'A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)'
Joo-Leng Low, Dawn Pingxi Lau, Xiaoqian Zhang, et al.
Ebiomedicine
|
February 2, 2021
A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)
Joo-Leng Low, Dawn Pingxi Lau, Xiaoqian Zhang, et al.
Plos One
|
December 22, 2018
Red blood cell phenotype fidelity following glycerol cryopreservation optimized for research purposes
Stephen C Rogers, Laura B Dosier, Timothy J McMahon, et al.
Science Translational Medicine
|
January 14, 2026
An antibody cocktail targeting conserved, nonoverlapping epitopes prevents viral escape and confers protection against RSV in vivo
Yongpeng Sun, Liqin Liu, Zemin Jiang, et al.
Nature Medicine
|
September 19, 2017
Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma
Daniel S W Tan, Fui Teen Chong, Hui Sun Leong, et al.
Chinese Journal of Integrative Medicine
|
July 5, 2014
Expert consensus for postmarketing Chinese medicine intensive hospital safety monitoring
Xing Liao, Wen Zhang, Yan-Ming Xie, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
|
January 30, 2014
[Technical specifications for intensive hospital safety monitoring of post-marketing Chinese medicine (draft version for comments)]
Yan-Ming Xie, Xing Liao, Yu-Bin Zhao, et al.
The Lancet Regional Health. Western Pacific
|
June 20, 2025
Early intensive blood pressure management after endovascular treatment in ischaemic stroke (IDENTIFY): a multicentre, open-label, blinded-endpoint, randomised controlled trial
Xuening Zhang, Le Cao, Simiao Wu, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
|
September 26, 2017
[Expert consensus on the design and implementation of clinical safety centralized monitoring study of Chinese medical injection]
Jun-Hua Zhang, Jing-Tian Ren, Jing-Qing Hu, et al.
Nature Communications
|
September 7, 2017
Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time
Shumei Chia, Joo-Leng Low, Xiaoqian Zhang, et al.
Page
of 89
Search research articles
Search
Showing results (871-880 of 885) with videos related to
Sort By:
Page
of 89
Ebiomedicine
|
April 16, 2021
Corrigendum to 'A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)'
Joo-Leng Low, Dawn Pingxi Lau, Xiaoqian Zhang, et al.
Ebiomedicine
|
February 2, 2021
A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)
Joo-Leng Low, Dawn Pingxi Lau, Xiaoqian Zhang, et al.
Plos One
|
December 22, 2018
Red blood cell phenotype fidelity following glycerol cryopreservation optimized for research purposes
Stephen C Rogers, Laura B Dosier, Timothy J McMahon, et al.
Science Translational Medicine
|
January 14, 2026
An antibody cocktail targeting conserved, nonoverlapping epitopes prevents viral escape and confers protection against RSV in vivo
Yongpeng Sun, Liqin Liu, Zemin Jiang, et al.
Nature Medicine
|
September 19, 2017
Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma
Daniel S W Tan, Fui Teen Chong, Hui Sun Leong, et al.
Chinese Journal of Integrative Medicine
|
July 5, 2014
Expert consensus for postmarketing Chinese medicine intensive hospital safety monitoring
Xing Liao, Wen Zhang, Yan-Ming Xie, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
|
January 30, 2014
[Technical specifications for intensive hospital safety monitoring of post-marketing Chinese medicine (draft version for comments)]
Yan-Ming Xie, Xing Liao, Yu-Bin Zhao, et al.
The Lancet Regional Health. Western Pacific
|
June 20, 2025
Early intensive blood pressure management after endovascular treatment in ischaemic stroke (IDENTIFY): a multicentre, open-label, blinded-endpoint, randomised controlled trial
Xuening Zhang, Le Cao, Simiao Wu, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
|
September 26, 2017
[Expert consensus on the design and implementation of clinical safety centralized monitoring study of Chinese medical injection]
Jun-Hua Zhang, Jing-Tian Ren, Jing-Qing Hu, et al.
Nature Communications
|
September 7, 2017
Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time
Shumei Chia, Joo-Leng Low, Xiaoqian Zhang, et al.
Page
of 89